Israel Corp. Reports Results for First Quarter of 2025
MWN-AI** Summary
Israel Corporation Ltd. (TASE: ILCO) announced its financial results for the first quarter of 2025, highlighting a net profit of $35 million, down from $62 million in the same period last year. The company's share in the profit from ICL was recorded at $40 million, compared to $48 million in Q1 2024. Notably, ILCO did not report any profit from Prodalim, reflecting its recent investment strategy.
Amortization of excess costs from held companies increased slightly, setting at $(2) million versus $(1) million in the previous year. Additionally, general and administrative expenses rose to $(5) million from $(1) million, while ILCO’s tax income dropped significantly to $2 million from $16 million in Q1 2024.
As of March 31, 2025, ILCO showcased a total financial liability of $723 million alongside liquid assets of $781 million, yielding a net cash position of $21 million. This marks a decline from a net cash position of $126 million at year-end 2024.
In terms of corporate developments, ILCO completed an investment deal in Prodalim on March 5, 2025, acquiring approximately 27.5% of the company, which specializes in natural solutions for various industries, including the burgeoning sector of de-alcoholization of beverages. On March 27, 2025, the Board of Directors announced a dividend distribution of $15 million, consistent with its previously outlined dividend policy.
ILCO remains focused on expanding its portfolio, especially in food tech, agriculture, healthcare, and Industry 4.0 sectors, as part of its strategic vision stated in November 2019. Overall, despite a dip in profitability, ILCO's solid asset base and strategic investments suggest a proactive approach to navigating market challenges.
MWN-AI** Analysis
Israel Corporation Ltd. (TASE: ILCO) reported its first-quarter results for 2025, revealing a challenging yet opportunistic landscape for investors. While net profit for ILCO’s shareholders decreased to $35 million from $62 million year-over-year, the company’s strategic investments and strong asset base continue to present potential upside for discerning investors.
Key highlights include a significant reduction in profit contribution from ICL, down to $40 million from $48 million. Despite this decline, ILCO's liquidity position remains stable, with total liquid assets amounting to $781 million against liabilities of $723 million. This translates into a net cash position of $21 million, although it marks a decrease from the net cash of $126 million reported at year-end 2024. It is critical for investors to monitor liquidity closely as fluctuations in cash flow can impact operational flexibility and dividend sustainability.
An optimistic aspect of the report is ILCO’s investment in Prodalim, which now constitutes a 27.5% stake. Prodalim operates in high-growth sectors such as natural ingredients and product innovation in alcoholic beverage de-alcoholization. This move aligns with ILCO’s strategic focus on sectors like food tech and healthcare, which could enable enhanced revenue streams in the future.
Additionally, the board's decision to declare a $15 million dividend underscores a commitment to shareholder returns despite current profit pressures. This action indicates a stable operational model and may appeal to income-focused investors.
In conclusion, while the current quarterly results reflect some financial pressures, ILCO’s solid asset base, strategic investments, and dividend policy present a compelling case for investors looking for long-term growth opportunities in key sectors. Caution is advised, but a gradual accumulation of ILCO shares may yield positive long-term returns as the company realigns its portfolio strategy.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
TEL AVIV, Israel , May 21, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its first quarter results for the period ending March 31, 2025 .
Selected Financial Figures for the First Quarter 2025: | ||
| Q 1 /2 5 | Q 1 / 24 |
ILCO share in ICL profit | 40 | 48 |
ILCO share in Prodalim profit | - | - |
Amortization of excess cost in held companies | (2) | (1) |
Financing income, G&A and other expenses at ILCO headquarter level | (5) | (1) |
Tax income of ILCO Headquarters | 2 | 16 |
Net profit to company's shareholders | 35 | 62 |
Liquidity at the ILCO Headquarters Level [1]
As of March 31, 2025 , total financial liabilities were $723 million , and investments in liquid assets amounted to $781 million of which $10 [2] million are pledged deposits.
Net cash [1] as of March 31, 2025 , totaled $21 million . The net cash includes the fair value of derivatives transactions, which increases the economic value of the financial liabilities by $37 million . As of December 31, 2025 , the net cash was $126 million .
Additional updates
On March 5, 2025 , ILCO completed the investment agreement with Prodalim Investments Ltd, ("Prodalim"), dated January 21, 2025 , after the completion of the transaction, ILCO holds approximately 27.5% of Prodalim's share capital, on a fully diluted basis. Prodalim is a private company, incorporated in Israel , which is engaged in creating natural solutions for various industries. Its products include concentrates, flavors and fragrances, beverage bases and other natural functional ingredients. In addition, Prodalim is developing innovative activities focused on the emerging world of the de-alcoholization of alcoholic beverages*
On March 27, 2025 , ILCO Board of Directors decided on distribution of dividend at the sum of $15m , this in accordance with the company's dividend policy announced in January 2023 . The record date was April 9, 2025 , and the payment date was April 21, 2025 .
ILCO financial results of ILCO are mainly affected by the results of its investees. For more details see detailed financial report.
ILCO Total Assets, Net | |
| 31/03/2025 |
Assets | |
ICL (~567m shares, market value) | 3,186 |
Prodalim (book value) | 118 |
AKVA Group (~6.6m shares, market value) | 44 |
Other [3] | 16 |
Total Assets | 3,364 |
ILCO's Net Cash | 21 |
Total Assets, net | 3,385 |
About Israel Corporation
Israel Corporation Ltd. (TASE: ILCO) ("ILCO") is a reputable public investment company, which owns and invests in high quality companies with established managements and go-to markets.
In November 2019 , ILCO announced its updated strategy, ILCO plans to expand its portfolio through new investments over the next few years. ILCO plans to focus mainly on the food (inc. tech), agriculture (inc. tech), healthcare and industry 4.0 sectors. For more details please see the following link to ILCO updated Strategy Presentation
ILCO strives to generate return on its investment through active board participations and its operational and managerial expertise.
ILCO current core holdings include c.44% stake in ICL Group (NYSE:ICL, TASE:ICL), c.18% stake in AKVA Group (OB:AKVA) and 27.5% in Prodalim (on a fully diluted basis).
ILCO is publicly traded on the Tel Aviv Stock Exchange under the ticker ILCO and is included in the TA-35 Index.
For further information on ILCO, see ILCO's publicly available filings, which can be found on the Tel Aviv Stock Exchange website at http://maya.tase.co.il .
Please also see ILCO company website http://www.israelcorp.com for additional information.
Convenience Translation
The financial information found in this press release is an English summary based on the original Hebrew financial statements and is solely for the convenience of the reader. The binding version is the original in Hebrew.
Forward Looking Statements
This press release may contain forward-looking statements, which may not materialize and are subject to risks and uncertainties that are not under the control of ILCO, which may cause actual results to differ materially from those contained in the disclosures.
Investor Relations Contacts
Idan Hizki
Vice President, Business Development
Tel: +972 3 684 4500
idanh@israelcorp.com
[1] Israel Corp and its wholly owned and controlled headquarter companies.
[2] Following the end of the quarter, the balance is $8m
[3] Includes 1.983m shares in Nordic Aqua Partners (OB:NOAP).
SOURCE Israel Corporation Ltd.
FAQ**
How does the Q1 2025 net profit of $35 million for Israel Corp. Ltd. IRLCF compare to the previous year's result of $62 million, and what factors contributed to this decrease?
With the recent liquidity position showing $million in net cash, what strategies does Israel Corp. Ltd. IRLCF plan to implement to improve cash flow moving forward?
How will Israel Corp. Ltd. IRLCF leverage its 27.5% stake in Prodalim to enhance profitability, especially with Prodalim's focus on natural solutions and de-alcoholization innovations?
What impacts do the recent dividend distribution and changes in financing income and expenses have on Israel Corp. Ltd. IRLCF's overall financial health for 2025?
**MWN-AI FAQ is based on asking OpenAI questions about Israel Corporation Ltd (OTC: IRLCF).
NASDAQ: IRLCF
IRLCF Trading
2485.27% G/L:
$238 Last:
7 Volume:
$238 Open:
